EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In Vitro Safety Study on the Use of Cold Atmospheric Plasma in the Upper Respiratory Tract

Sigrid Karrer iD, Petra Unger, Michael Gruber iD, Lisa Gebhardt iD, Robert Schober iD, Mark Berneburg, Anja Katrin Bosserhoff iD, Stephanie Arndt

Cells · 2024

DOI: 10.3390/cells13171411 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2024. Verfasst von Sigrid Karrer und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, University Medical Center Regensburg, 93053 Regensburg, Germany. Hauptthemen laut MEDLINE: Plasma Gases. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Terraplasma medical GmbH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cold atmospheric plasma (CAP) devices generate reactive oxygen and nitrogen species, have antimicrobial and antiviral properties, but also affect the molecular and cellular mechanisms of eukaryotic cells. The aim of this study is to investigate CAP treatment in the upper respiratory tract (URT) to reduce the incidence of ventilator-associated bacterial pneumonia (especially superinfections with multi-resistant pathogens) or viral infections (e.g., COVID-19). For this purpose, the surface-microdischarge-based plasma intensive care (PIC) device was developed by terraplasma medical GmbH. This study analyzes the safety aspects using in vitro assays and molecular characterization of human oral keratinocytes (hOK), human bronchial–tracheal epithelial cells (hBTE), and human lung fibroblasts (hLF). A 5 min CAP treatment with the PIC device at the “throat” and “subglottis” positions in the URT model did not show any significant differences from the untreated control (ctrl.) and the corresponding pressurized air (PA) treatment in terms of cell morphology, viability, apoptosis, DNA damage, and migration. However, pro-inflammatory cytokines (MCP-1, IL-6, and TNFα) were induced in hBTE and hOK cells and profibrotic molecules (collagen-I, FKBP10, and αSMA) in hLF at the mRNA level. The use of CAP in the oropharynx may make an important contribution to the recovery of intensive care patients. The results indicate that a 5 min CAP treatment in the URT with the PIC device does not cause any cell damage. The extent to which immune cell activation is induced and whether it has long-term effects on the organism need to be carefully examined in follow-up studies in vivo.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Plasma GasesHumansCOVID-19KeratinocytesCytokinesFibroblastsApoptosisSARS-CoV-2Cell SurvivalEpithelial CellsRespiratory SystemLungDNA Damage

Stichwörter der Autor:innen

cold atmospheric plasma (CAP)human bronchial–tracheal epithelial cells (hBTE)human lung fibroblasts (hLF)human oral keratinocytes (hOK)plasma intensive care (PIC)pressurized air (PA)upper respiratory tract (URT)

Substanzen

Plasma GasesCytokines

Autor:innen und Institutionen

  • Department of Dermatology, University Medical Center Regensburg, 93053 Regensburg, Germany.
  • Department of Anesthesiology, University Medical Center Regensburg, 93053 Regensburg, Germany.
  • Terraplasma Medical GmbH, 85748 Garching, Germany.
  • Institute of Biochemistry, Friedrich-Alexander University of Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.
  • Comprehensive Cancer Center Alliance WERA (CCC WERA), 91054 Erlangen, Germany.
  • Bavarian Cancer Research Center (BZKF), 91054 Erlangen, Germany.

ORCID-Profile: Sigrid Karrer, Michael Gruber, Lisa Gebhardt, Robert Schober, Anja Katrin Bosserhoff

Förderung

  • Terraplasma medical GmbH

Zitieren

APA

Karrer, S., Unger, P., Gruber, M., Gebhardt, L., Schober, R., Berneburg, M., Bosserhoff, A. K., & Arndt, S. (2024). In Vitro Safety Study on the Use of Cold Atmospheric Plasma in the Upper Respiratory Tract. Cells. https://doi.org/10.3390/cells13171411

Vancouver

Karrer S, Unger P, Gruber M, Gebhardt L, Schober R, Berneburg M, et al. In Vitro Safety Study on the Use of Cold Atmospheric Plasma in the Upper Respiratory Tract. Cells. 2024. doi:10.3390/cells13171411

BibTeX
@article{Karrer2024,
  author = {Karrer, Sigrid and Unger, Petra and Gruber, Michael and Gebhardt, Lisa and Schober, Robert and Berneburg, Mark and Bosserhoff, Anja Katrin and Arndt, Stephanie},
  title = {In Vitro Safety Study on the Use of Cold Atmospheric Plasma in the Upper Respiratory Tract},
  journal = {Cells},
  year = {2024},
  doi = {10.3390/cells13171411}
}
Kostenlos starten →